Exhibitors & Sponsors
Accredo is a full-service specialty pharmacy dedicated to the treatment of rare and complex conditions. Our comprehensive therapy management programs engage trained pharmacists, nurses, reimbursement specialists and patient care representatives who provide enhanced support services to patients, their families and healthcare professionals.
AirXpanders® Inc., based in Silicon Valley, is focused on the design, manufacturing and marketing of innovative medical devices that help modernize breast reconstruction. The company’s flagship product, the AeroForm® Tissue Expander System, is the first and only FDA-cleared needle-free, patient-controlled tissue expander for breast reconstruction following a mastectomy.
Agendia is a privately held, leading molecular diagnostics company that develops and markets genomic diagnostic products, which help support physicians with their complex treatment decisions. Agendia’s breast cancer tests were developed using an unbiased gene selection by analyzing the complete human genome. Our offerings include the MammaPrint®, 70-Gene Breast Cancer Risk-of-Recurrence Test, and the BluePrint®, 80-Gene Molecular Subtyping Test that provides deeper insight leading to more clinically actionable breast cancer biology.
In addition, Agendia has a pipeline of other genomic products in development. For more information, you can visit Agendia’s patient site at www.KnowYourBreastCancer.com or the corporate site at www.agendia.com.
Founded in 1973, the American Brain Tumor Association (ABTA) was the first national nonprofit organization dedicated solely to brain tumors. For over 40 years, the ABTA has been providing comprehensive resources that support the complex needs of brain tumor patients and caregivers, as well as the critical funding of research in the pursuit of breakthroughs in brain tumor diagnosis, treatment and care.
The Association of Community Cancer Centers (ACCC) strives to be the leading education and advocacy organization for the multidisciplinary cancer team. Members rely on the Association to bring them information on cancer program management, reimbursement issues, legislative and regulatory changes, community cancer program standards, community clinical research, physician relationships, and more.
Boehringer Ingelheim is committed to discovering and developing cancer treatments for the benefit of patients. Our scientific discoveries and research are applied to develop a wide range of therapies in both solid tumors and hematologic cancers. Development programs include angiogenesis inhibition, signal transduction inhibition, and cell-cycle kinase inhibition, among others.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. We are committed to furthering the science and understanding of Immuno-oncology through our research and development, as well as by supporting educational activities.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
CanSurround provides Psychosocial Support through Digital Technologies for people living with cancer. Managing Stress and Building Resilience with the right Psychosocial Support Tools makes it easier to create emotional well-being. CanSurround digital solution is 24/7, helping patients in every phase of the cancer journey - diagnosis, throughout treatment and beyond.
Color’s mission is to democratize access to genetic information. For $249, Color provides a clinical-grade physician ordered test. The Color Test analyzes 30-genes to help women and men learn their risk for the most common hereditary cancers: breast, ovarian, colorectal, pancreatic and other cancers. Complimentary genetic testing included.
CVS Specialty - Our commitment to helping patients and their physicians manage complex drug therapies by delivering expert individualized care and unmatched, multi-channel access has made us one of the leading specialty pharmacies in the country. We provide a full-range of pharmaceutical care, dispensing the latest FDA-approved medications.
Daiichi Sankyo, Inc. is the U.S. subsidiary of Daiichi Sankyo, Co., Ltd. The Company currently markets therapies in hypertension, dyslipidemia, diabetes, acute coronary syndrome, thrombotic disorders, stroke risk reduction, opioid-induced constipation, IV iron therapy and metastatic melanoma. www.dsi.com.
Diplomat is the nation’s largest independent specialty pharmacy. We work with the entire healthcare ecosystem to connect patients who have chronic and rare conditions to medication, information, and funding. Our high-touch and uniquely personal approach is backed by exceptional results in patient satisfaction, prescriber satisfaction, adherence rates, and more.
Feel Good, Inc. provides portable TENS (transcutaneous electrical nerve stimulation) units offering wide variety of benefits, including alleviating back, nerve and diabetic pain and migraines. Our units can also improve circulation, sleep patterns and have been shown to decrease the use of pain relievers that can cause negative side effects.
Founded more than 35 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, CA.
HCA Healthcare is one of the nation’s leading providers of healthcare services, comprising of 177 hospitals and 119 freestanding surgery centers in 20 states and the United Kingdom. In addition, Sarah Cannon, the Cancer Institute of HCA Healthcare, offers integrated cancer services with convenient access to cutting-edge therapies in communities across the US & UK.
Hope Scarves is an international nonprofit organization based in Louisville, Kentucky with the mission to share scarves, stories and hope with people facing cancer.
Hope Scarves collects scarves and survivor stories then sends them to others facing cancer in a creative package including scarf tying instructions and encouragement from someone “who has been there.” Since founding in 2012, over 7000 Hope Scarves have been sent to people facing over 90 types of cancer in every state and 16 countries. The oldest recipient is 92 and the youngest, 4. Recognizing the importance of research, Hope Scarves also invests a portion of each dollar raised in Metastatic Breast Cancer Research totaling over $150,000 and counting. Hope Scarves has affectionately become known as the sisterhood of the traveling scarves.
Merck & Co.
For more than a century, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, Merck continues be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases around the world.
At Novartis, our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging health care issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
OncoNav by NextPath is software designed to match the work flow of today’s oncology nurse navigators and assist them in scheduling and tracking their patients from screening and diagnosis through treatment. OncoNav supports the creation of custom survivorship care plans and interfaces with other hospital systems to minimize data entry and avoid duplication of efforts. Our custom reporting module allows navigators to easily demonstrate program effectiveness.
Pfizer Oncology is committed to the discovery, investigation, and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline of biologics and small molecules, one of the most robust in the industry, is studied with precise focus on identifying and translating the best scientific breakthroughs into clinical application for patients across a wide range of cancers. By working collaboratively with academic institutions, individual researchers, cooperative research groups, governments, and licensing partners, Pfizer Oncology strives to cure or control cancer with breakthrough medicines, to deliver the right drug for each patient at the right time.
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma is dedicated to advancing the treatment of HER2+ breast cancer and supporting women, their families and the breast cancer community.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare—a strategy that aims to fit the right treatment to each patient in the best way possible.
Sharsheret supports young Jewish women and families facing breast cancer at every stage―before, during, and after diagnosis. We provide educational resources, offer support to those at high risk of developing breast or ovarian cancer, and create programs for women and families to improve their quality of life.
Taiho Oncology has built a world-class clinical development organization that works urgently to develop innovative cancer treatments. Taiho is focused on bringing novel technology to cornerstone chemotherapies for a wide range of tumor types, including colorectal cancer and a variety of solid tumors.
Sirtex Medical develops and delivers oncology treatments using novel small particle technology to improve outcomes for patients with cancer. SIR-Spheres® Y-90 resin microspheres target liver tumors with radiation via the hepatic artery during Selective Internal Radiation Therapy (SIRT). Recent SIRFLOX Study data showed a 7.9 month improvement in Progression-Free Survival in the liver for patients with unresectable mCRC treated first line with SIR-Spheres Y-90 resin microspheres plus standard chemotherapy.
Our mission is unchanged as we endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation, and passion for improving the lives of patients. This singular focus drives our aspiration to discover, develop, and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, we are finding innovative ways to improve the treatment of cancer.
We’ve built a portfolio of paradigm-changing therapies and a leading oncology pipeline. While we’ve made great strides in our fight against cancer, we are determined to do more—to work harder and to reach higher. We will do this with the same passion, agility, and entrepreneurial spirit that has sustained the heart of our culture and has made us the leader in oncology that we are today.
We know that our mission is not a quick or easy one, but we are up to the task: we aspire to cure cancer.
Teva Oncology is a top US oncology company that strives to improve the lives of people affected by cancer. Our focus is to provide solutions in hematologic malignancies, solid tumors and supportive care. Teva Oncology's vision is to change the course of cancer care one patient at a time.
The University of Florida Health Cancer Center in Gainesville is dedicated to serving the residents of Florida with state-of-the-art cancer treatment, prevention, control and education. UF Health Cancer Center provides patients access to advanced medical treatment and the latest in research. As an academic health center, our clinician-scientists participate in cutting-edge research and clinical trials.